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Urgent healthcare
utilisation;
Systematic review;
Meta-regressionObjective: To examine the characteristics of complex interventions intended to reduce the use
of urgent and unscheduled healthcare among people with COPD.
Data sources: Electronic searches of MEDLINE, EMBASE, PSYCINFO, CINAHL, the British Nursing
Library and the Cochrane library, from inception to 25th January 2013 were conducted. These
were supplemented by hand-searching bibliographies and citation tracing identified reviews
and eligible studies.
Study selection: Studies were eligible for inclusion if they: i) included adults with chronic
obstructive pulmonary disease, ii) assessed the efficacy of a complex intervention using rando-
mised controlled trial design, and iii) included a measure of urgent healthcare utilisation at
follow-up.
Data extraction: Data on the subjects recruited, trial methods used, the characteristics of
complex interventions and the effects of the intervention on urgent healthcare utilisation
were extracted from eligible studies.
Results: 32 independent studies were identified. Pooled effects indicated that interventions
were associated with a 32% reduction in the use of urgent healthcare (OR Z 0.68, 95%
CIZ 0.57, 0.80). When study effects were grouped according to the components of the inter-
ventions used, significant effects were seen for interventions that included general education
(OR Z 0.66, 95% CI Z 0.55, 0.81), Exercise (OR Z 0.60, 95% CI Z 0.48, 0.76) and relaxation
therapy (OR Z 0.48, 95% CI Z 0.33, 0.70).
Conclusions: Use of urgent healthcare in patients with COPD was significantly reduced by com-
plex interventions. Complex interventions among people with COPD may reduce the use of ur-
gent care, particularly those including education, exercise and relaxation.
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COPD is an important cause of morbidity and mortality
worldwide, it was the fifth leading cause of death in 2002
and is predicted to be the fourth by 2030.1 It is associatedwith severe impairment in quality of life, disability and
increased healthcare use.2,3 A recent cross country, cross
sectional survey has shown that, while the greatest pro-
portion of healthcare use was in primary care, hospital
inpatient care accounted for 68% of total COPD healthcare
428 C. Dickens et al.costs. The cost was the highest in the UK at £277 per pa-
tient, per month.2
A considerable proportion of the healthcare cost of
people with COPD is attributable to the use of expensive
unscheduled and urgent healthcare (henceforth urgent
healthcare) rather than purposefully designed routine ser-
vices. Two previous studies found that as many as 26% of
COPD patients will make emergency department visits
annually and that 13% of patients will make 6 or more
visits.4,5 COPD is associated with high prevalence of
depression (26%) and anxiety (10e55%).6,7 Among people
with long term conditions (LTCs), anxiety and depression
are closely associated with poorer health outcomes,8,9
greater healthcare utilisation10,11 and increased use of ac-
cident and emergency departments.12,13 In COPD in
particular, depression and anxiety have been shown to be
significantly associated with increased risk of emergency
department visits, hospitalisations and higher urgent care
costs,14e22 though it remains unclear whether the influence
of anxiety and depression is causal or not.23
Current UK government policy recommends that un-
scheduled use of care should be reduced in people with
LTCs by introducing alternative pathways in primary care24;
COPD is one of several LTCs which are cited as being
potentially amenable to early prevention or intervention
within the community as an alternative to emergency
admission.25 Previous studies have shown that interventions
can reduce use of urgent healthcare, though these in-
terventions have usually involved multiple components and
therefore can be considered complex. They also vary with
regards to the intensity and setting in which interventions
have been delivered and professionals involved. As a result
the effects of such complex interventions have been
very mixed among people with COPD, and the components
of interventions associated with a reduction in urgent
healthcare remain obscure.
We have conducted a systematic review of the literature
with meta-regression to identify the characteristics of
complex interventions that reduce the use of urgent
healthcare among people with COPD. Identification of such
characteristics would facilitate the design of optimal in-
terventions with potential to reduce use of urgent health-
care and thus result in considerable savings in healthcare
expenditure. We did not limit the studies included on the
types of complex interventions delivered or by the type of
urgent healthcare used, to ensure capture of maximum
relevant data.g Since we anticipated differing thresholds for hospital admissions
between countries and over time, for the purposes of this review
hospitalisations were only considered urgent if they were described
as such in the published paper, if hospitalisations were described as
being the result of an acute exacerbation of underlying LTC or if
researchers confirmed that hospitalisations were urgent.Method
Studies were eligible for inclusion in the review if they met
the following criteria.
a) Included adults with COPD.
b) Assessed the efficacy/effectiveness of a complex inter-
vention. For the purposes of this review, complex in-
terventions involved multiple components and/or
multiple professionals, and could be delivered on an in-
dividual or group basis, or using technology such as
telephone or computer. Interventions could include ed-
ucation, rehabilitation, psychological therapy, socialintervention (social support, support group), organisa-
tional intervention (such as collaborative care or case
management), also drug trials targeting a psychological
problem, e.g. anxiety or depression. Simple in-
terventions, such as the introduction of a new treatment
targeting the underlying long term condition, compared
to treatment as usual were not included in this review.
c) Assessed urgent healthcare use as an outcome, e.g.
emergency department visits, urgent hospitalisationg or
unscheduled GP visits.
d) Used randomised controlled trial design.
Studies were not excluded by date or language of pub-
lication, sample size or follow up period. See Online
appendix (pages 2 to 3) for full PICO criteria. Unpublished
studies and those published in abstract form only, were not
included in this review.
Electronic search strategies were developed in-team, in
consultation with librarians with experience of performing
systematic reviews (RM). Search strategies were peer
reviewed by experts from within the University (LG) and
modified accordingly. Search strategies included terms rele-
vant to prospective studies and also COPD, with further
limiting to randomised controlled trials of complex in-
terventions in COPD using hand searching (see pages 4e17 in
Onlineappendix fordetails of searchstrategiesused).Wewere
not able to develop sensitive and reliable strategies to identify
studies investigating use of urgent healthcare specifically, so
searches were developed to identify all healthcare use, and
further restriction to relevant papers was achieved by hand
searching potentially eligible papers.
Searches were conducted in MEDLINE, EMBASE, PSY-
CHINFO, CINAHL, The British Nursing Index (using the OVID
search interface) and the Cochrane Library, from inception
of each database. Electronic searches were first conducted
on 19th August 2008 and then updated on 1st December
2011 and again on 25th January 2013. Electronic searches
were further supplemented by hand searches of the refer-
ence lists of papers meeting PICO criteria and relevant re-
views identified through searching electronic databases. All
titles and abstracts of papers identified by these means
were screened by two researchers (AB, AK) to identify
studies potentially meeting the inclusion criteria, with
disagreements being resolved by discussion. Full text re-
ports of studies that were potentially relevant to this re-
view were screened by two researchers (AB, AK) to
determine eligibility. To avoid double counting studies,
findings for any population presented in multiple publica-
tions were included only once in this review. See Fig. 1 for a
summary of the study selection process.
Data extraction
Standardised electronic data extraction sheets were
developed by the team and modified after piloting on the
Figure 1 PRISMA flow diagram.
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the participants, the characteristics of the intervention,
the methodological characteristics of the study and the
effects of the intervention on the use of urgent healthcare.
The characteristics of the complex interventions were
coded according to the following 11 key characteristics,
that were generated a priori26: general education, general
discussion, skills training, exercise, behaviour therapy,
relapse prevention, problem solving, cognitive behavioural
therapy, social support, relaxation and biofeedback (see
Page 2 of Online appendix for working definitions of inter-
vention components). Intervention components not fitting
the description required for the above categories or
not described in sufficient detail were recorded as
“miscellaneous”.26
Primary data extractionwas performedby two researchers
(AK, AB), with discussion between researchers and another
member of the team (CD) where there was uncertainty in any
aspect of data interpretation or extraction.
Risk of bias in individual studies
The methodological quality of the individual psychological
intervention trials was assessed using a component
approach27 by assessing whether:
i) the allocation sequence adequately generated
(e.g. random number lists, computer generation,
tossing a coin etc),ii) used adequate methods to conceal treatment alloca-
tion from researcher recruiting patients,
iii) knowledge of the allocated intervention was
adequately prevented during the study,
iv) incomplete outcome data was adequately dealt with,
v) reports of the study were free from suggestion of se-
lective outcome reporting,
vi) the study apparently was free of other problems that
could put it at risk of bias.
For the meta-analysis, a binary measure of quality was
used, determined by whether concealment of treatment
allocation was used or not.28
Quality for each study was assessed by two researchers
(AB, AK) and any uncertainties were resolved by discussion
within the team (AB, AK, CD).
Statistical analysis
Odds ratios (ORs) and 95% confidence intervals (95% CIs)
were calculated for each study where number of subjects
using urgent healthcare and the total number of subjects in
each trial arm were presented.27 The odds ratio is the ratio
of the odds of urgent healthcare in intervention group to
the odds of urgent healthcare in control group.
An OR equal to 1 would indicate that there is no dif-
ference in effect between the intervention and control
group whereas an OR <1 indicated that the intervention
reduced the use of urgent healthcare.27 Where data were
430 C. Dickens et al.presented in alternative formats, for example where sum-
mary tests results or where continuous data were pre-
sented, appropriate transformations were made.29
In cases where follow-up data were collected at mul-
tiple time points, ORs were calculated for the follow-up
data collected nearest to 1 year to maximise consistency
across studies. Where studies included more than one
measure of urgent healthcare, effects for each measure
were pooled. Where studies included more than 1 inter-
vention group, the data for each was entered as separate
records and the sample size in the control group was
halved. Effects of interventions were combined across
independent studies using random effects models,
weighted using the inverse of the variance.30 Heteroge-
neity among studies was assessed using Cochrane Q, where
a large Q value indicates the presence of heterogeneity,
and the I2 statistic. The I2 gives the percentage of vari-
ability in the effect estimate that is due to heterogeneity
rather than to chance. Suggested thresholds for the
interpretation of I2 are as follows: less than 40% indicate
there is no problem with heterogeneity, 30e60% indicates
a moderate problem, 60e90% a substantial problem and
75% and over considerable heterogeneity.27,31 Publication
bias was assessed using funnel plots and Eggers’ regression
method.27,32,33 Funnel plots are a scatter plot of the effect
estimates from each individual trial included in the review
plotted against their relative sample size. If publication
bias is present the results of smaller studies with non-
significant results will not be present in the graph and
there will be a gap at the bottom of the plot. However, if
publication bias is not present the plot will look like a
symmetrical, inverted funnel.27,32
Differences in effect across the methodological charac-
teristics of the trials including, i) the features of the study
population, ii) the methods of delivering the intervention
and iii) the methods of the trial itself, were assessed using
the analogue to Analysis of Variance for categorical vari-
ables,29 and univariate meta-regression was used for
continuous variables. Meta-regression is a type of sub-
analysis which can be used where studies share the same
characteristics, for example the same intervention com-
ponents, and therefore may yield different results from
other studies with different intervention compo-
nents.27,34,35 To identify which intervention components
were independently associated with reductions in urgent
healthcare, intervention components were entered into a
random effects multivariate meta-regression.34,35
Effects for interventions are presented in text, tables
and forest plot.
Meta-analyses were performed using Comprehensive
Meta-analysis (version 2.2.048, Nov 7th 2008) and Stata
(version 12, StataCorp LP, Texas, US).
Results
Details of studies included
Thirty-two independent studies met criteria for inclusion in
this review that included 3941 patients with COPD.36e67
Sample sizes for randomised controlled trials varied from
26 to 554 subjects, with an average sample size of 123. Ninestudies provided information on 2 different measures of
urgent care, and one provided information on 3. One study
had 2 intervention groups, resulting in a total of 43 records
from which to estimate the effect. Twenty-four records
assessed attendance at the emergency department, 12
assessed urgent hospitalisation, 7 assessed other sources of
urgent care (such as emergency visits to primary or sec-
ondary care, non-specified urgent doctor visits, ambulance
calls etc). Ten studies obtained unscheduled care data from
patient records, 5 from self-reports, 11 used a combination
of sources, and for 7 studies the sources of urgent care data
were unclear. Length of follow-up varied from 1 to 24
months (mean Z 10.1 months) (See eTable 1 in Online
appendix for details of the methodological characteristics
of the studies included).
Details of patient populations
Two studies recruited male only samples and the remainder
(where stated) included mixed sex samples. Mean ages of
populations varied from 57.5 to 80.4 years. In 24 treatment
comparisons, patients were recruited from secondary care
setting, in 5 primary care, and in 4 interventions patients
were recruited from a combination of primary and sec-
ondary care settings (see eTable 1 in Online appendix for
characteristics of study populations).
Details of the intervention
With regard to the characteristics of the interventions, the
mean number of treatment components included within
each intervention was 2.9 (range 1e6 components). The
average number of treatment sessions (stated in 22 studies)
was 13.9 (range 1e60); in 9 studies the exact number of
additional health practitioner contacts associated with the
interventions were unclear, most frequently because the
number of contacts was flexible.
Treatment was delivered at home or in the community in
12 studies, in hospital or in a doctor’s clinic in 9 cases, and
in a combination of home/community and hospital/clinic in
9 cases. Treatment was delivered through face to face
contact in 19 studies, by telephone in 1 and a combination
of these in 13 cases. The intervention was delivered by a
non-mental health practitioner in 29 studies and a mental
health practitioner in 1 study. Treatment was delivered by a
multidisciplinary team in 18 studies and an unidisciplinary
team in 11 studies. Of the treatment comparisons included,
24 used a structured management plan, 28 included
scheduled follow-up, 11 included enhanced inter-
professional communications (see eTable 2 in Online
appendix for details of interventions).
Reports of the risk of bias in the individual studies var-
ied; 11 studies reported details of allocation concealment,
of which 8 described adequate methods of allocation
concealment and were considered to be of high methodo-
logical quality for the purposes of the meta-analysis (see
eTable 3 in Online appendix for details of study quality).
Effect sizes for individual studies are presented in the
forest plot in Fig. 2. Overall the combined effect across
the 33 comparisons indicated that interventions were
associated with a reduction in the use of urgent care
NOTE: Weights are from random effects analysis
Overall  (I-squared = 37.4%, p = 0.017)
Tougaard et al
McGeoch et al
Rea et al
Rice et al
Hernandez et al
Bourbeau et al
Jarab et al
Boxall et al
Sridhar et al
Casas et al
Gallefoss et al
Seymour et al
Wong et al
Trappenburg et al
Gadoury et al
Koff et al
Ko et al
Bergner et al
Guell et al
Martin et al
Farrero et al
Eaton et al
Hermiz et al
Ries et al
Author
Man et al
Lee et al
Khdour et al
Smith et al
Wakayabayashi et al
Lobato et al
Wood-Baker et al
Bergner et al
Soler et al
1992
2006
2004
2010
2003
2003
2012
2005
2007
2006
2000
2010
2005
2011
2004
2009
2011
1988
2000
Year of
2004
2001
2009
2002
2003
publicatin
2004
2002
2009
1999
2011
2005
2006
1988
2006
0.68 (0.57, 0.80)
0.39 (0.17, 0.86)
1.24 (0.70, 2.21)
0.41 (0.12, 1.37)
0.68 (0.50, 0.92)
0.37 (0.17, 0.81)
0.43 (0.24, 0.77)
0.68 (0.37, 1.26)
1.00 (0.25, 4.06)
0.49 (0.24, 1.00)
0.63 (0.35, 1.12)
0.75 (0.15, 3.73)
0.34 (0.08, 1.45)
0.36 (0.14, 0.93)
1.00 (0.62, 1.60)
0.66 (0.39, 1.10)
0.30 (0.03, 3.14)
1.02 (0.41, 2.56)
0.72 (0.37, 1.41)
0.42 (0.16, 1.06)
Odds
2.34 (1.09, 5.03)
0.32 (0.15, 0.67)
0.79 (0.35, 1.78)
0.28 (0.06, 1.35)
1.00 (0.54, 1.84)
ratio (95% CI)
0.16 (0.03, 0.94)
0.99 (0.46, 2.11)
0.48 (0.24, 0.96)
2.76 (0.95, 7.98)
0.66 (0.30, 1.43)
0.09 (0.00, 1.78)
0.95 (0.49, 1.87)
0.78 (0.40, 1.53)
0.50 (0.12, 2.05)
100.00
3.10
4.56
1.68
7.17
3.15
4.49
4.22
1.30
3.64
4.52
1.03
1.24
2.49
5.47
5.05
0.50
2.56
3.85
2.50
%
3.28
3.35
3.04
1.05
4.29
Weight
0.86
3.33
3.74
2.05
3.23
0.32
3.85
3.81
1.29
Negative  Positive 
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Figure 2 Effect sizes and 95% confidence intervals for included studies.
Interventions that reduce urgent healthcare in COPD 431(OR Z 0.68, 95% CI Z 0.57, 0.80). A moderate degree of
heterogeneity was seen across studies (Q Z 51.1 df Z 32,
p < 0.0005, I2 Z 37.4%).32
Variations in effect across methodological characteris-
tics is seen in Table 1. There was a non-significant trend for
effects to be greatest among studies that had recruited
subjects from secondary care (p Z 0.10).) The effect sizes
of the interventions did not vary significantly with the mean
age of patients, the gender mix, where patients were
recruited, how or where treatments were delivered, who
delivered treatment, how it was organised or study quality
(Table 2).
When study effects were grouped according to the
components of interventions used, significant effects on
the use or urgent care were seen for interventions thatincluded general education (OR Z 0.66), Exercise
(OR Z 0.60) and relaxation therapy (OR Z 0.48). There
were non-significant trends for use of urgent care to be
reduced by interventions that included skills training
(ORZ 0.72) and relapse prevention (ORZ 0.77). No studies
had used behavioural interventions, CBT, problem solving
or had focussed on increasing social support. Among studies
of higher methodological quality (i.e. that concealed
treatment allocation) effect sizes were comparable for
education, exercise and relaxation and skills training: ed-
ucation (9 studies, pooled ORZ 0.65, pZ 0.004), exercise
(6 studies, pooled OR Z 0.65, p Z 0.069), relaxation (3
studies, pooled ORZ 0.52, pZ 0.012) and skills training (2
studies, pooled OR Z 0.55, p Z 0.14). Effects for relapse
prevention were small and non-significant (2 studies,
Table 1 Impact of methodological characteristics on effects sizes.
n OR (95% CI) p Comparison across groups
Nature of patients recruited
Mean age of subjects 33 0.01 (0.04, 0.07) 0.587
Percentage male 32 0.005 (0.01, 0.004) 0.28
Patient recruitment
Primary care 5 0.89 (0.52, 1.52) 0.67
Secondary care 24 0.59 (0.50, 0.70) <0.0005 Q Z 4.6, d.f. Z 2, p Z 0.10
Combined 4 1.06 (0.55, 2.04) 0.86
Characteristics of intervention
Where delivered
Hospital/clinic 9 0.61 (0.43, 0.86) 0.005
Home/community 12 0.69 (0.50, 0.97) 0.031 Q Z 0.39, df Z 2, p Z 0.82
Combined 9 0.70 (0.50, 0.99) 0.043
Mode of delivery
Face-to-face 19 0.72 (0.54, 0.96) 0.023
Telephone 1 0.36 (0.14, 0.93) 0.034 Q Z 1.92, df Z 2, p Z 0.38
Combined 13 0.66 (0.53, 0.82) <0.0005
Number of intervention sessions 22 0.003 (0.011, 0.017) 0.64
Delivered by
Non-mental health professional 29 0.66 (0.53, 0.82) <0.0005
Mental health professional 1 0.68 (0.50, 0.92) 0.013 Q Z 0.02, df Z 1, p Z 0.89
Multidisciplinary team 16 0.70 (0.52, 0.95) 0.021 Q Z 0.02, df Z 1, p Z 0.89
Unidisciplinary team 11 0.68 (0.56, 0.83) <0.0005
Structured management plan 24 0.66 (0.54, 0.81) <0.0005 Q Z 0.2, df Z 1,p Z 0.69
No structured management plan 9 0.72 (0.50, 1.06) 0.093
Scheduled follow-up 28 0.66 (0.55, 0.80) <0.0005 Q Z 0.60,df Z 1, p Z 0.44
No scheduled follow-up 5 0.78 (0.53, 1.15) 0.21
Enhanced inter-professional communication 11 0.84 (0.58, 1.22) 0.37 Q Z 2.4, df Z 1, p Z 0.12
No enhanced inter-professional communication 22 0.61 (0.53, 0.72) <0.0005
Did intervention constitute collaborative care
Yes 5 0.86 (0.45, 1.65) 0.65 Q Z 0.78,df Z 1, p Z 0.38
No 26 0.63 (0.53, 0.76) <0.0005
Methodological characteristic
Type of unscheduled carea
Emergency Department 24 0.70 (0.57, 0.85) <0.0005
Urgent hospital admissions 12 0.60 (0.48, 0.77) <0.0005 Q Z 0.8, df Z 2, p Z 0.67
Others 7 0.65 (0.37, 1.13) 0.13
Source of urgent care data
Records 10 0.62 (0.469, 0.83) 0.002
Self-report 5 0.67 (0.43, 1.05) 0.082 Q Z 0.1, df Z 2, p Z 0.95
Combined 11 0.62 (0.48, 0.81) <0.0005
Length of follow-up 33 0.005 (0.03, 0.04) 0.78
Higher study quality 8 0.71 (0.53, 0.96) 0.025 Q Z 1.0, df Z 1, p Z 0.32
Lower study quality 5 0.55 (0.37, 0.83) 0.005
a There are 43 comparisons for type of unscheduled care from 32 studies.
432 C. Dickens et al.pooled OR Z 0.94, p Z 0.77). On multivariate meta-
regression, no individual treatment components contrib-
uted significantly to the regression model.
Publication bias
The funnel plot did appear asymmetrical, with a relative
absence of small studies in which interventions were asso-
ciated with increased use of urgent care (Fig. 3), though
Egger’s regression method did not confirm a statistically
significant association between Log OR and standard error
of Log OR [Egger’s intercept Z 0.79, (95% CI 1.87 to
0.29), p Z 0.15].Discussion
We conducted a systematic review of intervention studies
in people with chronic obstructive pulmonary disease to
identify the characteristics of interventions associated with
a reduction in the use of urgent care. We identified 32
studies of complex interventions that had investigated use
of urgent care as an outcome. On meta-analysis we found
that use of urgent care was reduced significantly by com-
plex interventions (OR Z 0.68). This shows that complex
interventions can reduce the amount of urgent care used by
COPD patients by 32%, though the effects of individual
studies were moderately heterogeneous. When grouped by
Table 2 Types of treatment.
Variable OR (95%
confidence
intervals)
p Value
General education (n Z 28) 0.66 (0.55, 0.81) <0.0005
General discussion (n Z 3) 0.81 (0.51, 1.28) 0.35
Skills (n Z 13) 0.72 (0.49, 1.04) 0.080
Exercise (n Z 11) 0.60 (0.48, 0.76) <0.0005
Behaviour therapy (n Z 0) e e e
Relapse prevention (n Z 11) 0.77 (0.56, 1.07) 0.12
Problem solving (n Z 0) e e e
CBT (n Z 0) e e e
Increased social
support (n Z 0)
e e e
Relaxation therapy (n Z 4) 0.48 (0.33, 0.70) <0.0005
Interventions that reduce urgent healthcare in COPD 433the individual characteristics of the intervention we found
significant effects for studies that included education
(OR Z 0.66), exercise (OR Z 0.60), and relaxation
(OR Z 0.48), which can be interpreted as a 34%, 40% and
52% reduction in urgent care use respectively. There were
also non-significant trends for reduction in urgent care use
in studies that included skills training (OR Z 0.72,
p Z 0.080) and relapse prevention (OR Z 0.77, p Z 0.12).
No studies used cognitive behavioural therapy/behavioural
therapy or problems solving. There was no significant evi-
dence of publication bias. Overall, our findings may have
been inflated by inclusion of studies of low methodological
quality, though the effects for education, exercise, relax-
ation and skills training were comparable in the small
number of studies with high methodological quality.
Our review has a number of strengths. First, we con-
ducted extensive searches of key electronic databases and
also asked experts in the area about potentially relevant
studies to identify as many relevant studies as possible.
Second, rather than rely on the development of electronic
search strategies to identify papers relevant to the
construct of urgent healthcare, we kept our electronic
searches broad (i.e. searched all healthcare) and narrowed
to the relevant papers using rigorous hand-searching. Third
we did not limit the types of urgent healthcare included a
priori though we were very rigorous in the exclusion of0
.
5
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Figure 3 Funnel plot for included studies.studies for which it was not absolutely clear that the use of
healthcare was urgent. Finally, we did not limit our review
by the date or language of publication, sample size or
duration of follow-up to maximise the number of studies
included.
Our study has some weaknesses. First, the effects of
different complex interventions were moderately hetero-
geneous, so the pooled effect from all included studies
must be interpreted with caution. The pooled effects
across a wide range of complex interventions of varying
intensities, delivered in varying settings by different pro-
fessionals tells us little about which interventions might be
most effective in reducing the use of urgent care. Our
intention had always been to explore the extent to which
methodological characteristics influenced this heteroge-
neity, to identify intervention components associated with
reduced urgent care. Second, we focused entirely on
reduction in use of urgent care and we did not record
medical outcomes, such as health status, morbidity of
health related quality of life. As such we can draw no in-
ferences about effects of these complex interventions in
these other domains and cannot determine whether the
reductions in the use of urgent care were due to a reduction
in the need for urgent care, due to improved health, or
simply due to the substitution of urgent care by scheduled
care, delivered as part of the study intervention.
We interpret our findings as indicating that complex in-
terventions among people with COPD may reduce the use of
urgent care, particularly those including education, exer-
cise and relaxation. We acknowledge that the inclusion of
studies of low methodological quality may have inflated the
size of this effect, though the benefits to urgent care from
education, exercise, relaxation and skills training remained
significant among the minority of studies of high quality.
Since no individual study component made a significant
independent contribution in the multivariable meta-
regression, we conclude that, based on current evidence
among people with COPD, reductions in the use of urgent
care cannot be attributed to any single intervention
component.
Collaborative care is often suggested as a way to manage
individuals with complex needs, such as LTCs and depres-
sion. It is defined as interventions delivered by a multidis-
ciplinary team and including structured management plans,
scheduled follow up and enhanced inter-professional
communication.68 Collaborative care has previously been
shown to make significant improvements to both physical
and psychological health outcomes in patients with dia-
betes and coronary heart disease,69e72 post coronary artery
bypass graft patients73 and older adults with other comor-
bid medical conditions.71,74 Outside of the context of co-
morbid medical illness, there is emerging evidence that
collaborative care for the treatment of depression is cost
effective in terms of Quality Adjusted Life Years (QALY)75
and in reducing total healthcare costs.76 However, there
have been no economic evaluations of collaborative care
for treatment of depression comorbid with LTCs to date.
The interventions that met the criteria for collaborative
care in this review were not associated with reduced use or
cost of urgent care.
Psychological symptoms, especially depression, are
common in patients with COPD6,7 and associated with
434 C. Dickens et al.multiple adverse health outcomes including poor physical
functioning77e80 worse heath related quality of life,81
increased use of urgent healthcare23 and mortality.82,83
Yet, it is striking how few of the interventions we
reviewed included any form of psychosocial component,
although current NICE guidelines recommend active treat-
ment of depression in patients with long term conditions.84
In fact overall, there are very few studies of either anti-
depressant medication or psychosocial interventions for the
treatment of either depression or anxiety in COPD, and
most are of poor quality.85,86
Although the evidence is relatively weak, there is some
support for psychosocial interventions and their impact
upon anxiety in COPD. A study comparing the use of a
physical activity facilitator for patients with depression in
primary care found that it did not improve mood or reduce
antidepressant use when compared with usual care.87 Given
that we know that depression predicts greater use of urgent
healthcare,23 it may be that if exercise in COPD improves
depression it could also reduce urgent healthcare use.
Therefore, offering possibilities of integrating interventions
aimed at psychological and physical health outcomes.
In light of the findings of this systematic review, the
potential impact of targeted psychological/pharmacolog-
ical interventions to reduce unscheduled care in patients
with COPD and anxiety/depression requires evaluation.Conflict of interest statement
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